“Every day is a
different challenge.”
JUSTIN McCUE, PhD.
Senior Engineer, BioPharm Development
Justin McCue draws on the teambuilding skills he learned as a member of an NCAA championship gymnastics team to integrate with Regulatory, Manufacturing, and Quality groups.
“I just don't like
standing still.”
KATJA BULLER, M.D.
Senior Director, Public Affairs
Using her ability to communicate complex science in simple terms, Katja Buller has built upon her career as a physician to help people understand how our breakthrough therapies can impact people's lives.
“We are changing the
lives of those who
have no hope.”
LINDE T. SMITH
Area Business Manager, Neurology Sales
Linde Smith is an MS patient who joined Biogen Idec because he wanted to be part of the company's mission and bring hope to MS patients who are currently untreated.
“At Biogen Idec, we can
be creative and feel
free to take risks.”
SHA MI (MISHA), PhD.
Principal Investigator, Neurobiology
Misha discovered a molecule called LINGO which, when blocked, facilitates the regeneration of nerves. She is developing an anti-LINGO antibody that may revolutionize central nervous system treatment.
Biogen Idec Inc. (NASDAQ: BIIB) è tra le società leader a livello mondiale nel settore delle biotecnologie, grazie a una ricerca scientifica d’avanguardia capace di mettere a frutto le conoscenze più avanzate. Ricerca che sostiene l’impegno dell’azienda per la scoperta, lo sviluppo, la produzione e la commercializzazione di soluzioni terapeutiche innovative per gravi patologie nell’ambito della neurologia, immunologia ed emofilia.
